Barinthus Biotherapeutics plc Net Asset Quality Index

Latest as of September 2025: 77.4%

Barinthus Biotherapeutics plc net asset quality index. Barinthus Biotherapeutics plc (BRNS) has a Net Asset Quality Index of 77.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $109.20 Million minus total liabilities of $24.64 Million yields net assets of $84.56 Million. A higher index indicates a stronger, lower-leverage balance sheet. See BRNS book value for net asset value and shareholders' equity analysis.

Quality Index

77.4%
Equity / Total Assets

Net Assets

$84.56 Million
USD

Total Assets

$109.20 Million
USD

Total Liabilities

$24.64 Million
USD

Net Asset Quality Index of Barinthus Biotherapeutics plc (2019–2024)

Net asset quality index of Barinthus Biotherapeutics plc from 2019 to 2024. This chart shows how Barinthus Biotherapeutics plc's Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at 77.4%, representing net assets of $84.56 Million against total assets of $109.20 Million USD. Check BRNS strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Barinthus Biotherapeutics plc Net Asset Quality Index by Year (2019–2024)

Barinthus Biotherapeutics plc net asset quality index by year from 2019 to 2024. The table below presents the year-by-year Net Asset Quality Index for Barinthus Biotherapeutics plc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Barinthus Biotherapeutics plc market cap and net worth.

Year Quality Index Net Assets (USD) Total Assets Total Liabilities Change (pp)
2024 81.2% $130.13 Million $160.33 Million $30.19 Million ▼ -6.0 pp
2023 87.2% $187.00 Million $214.51 Million $27.51 Million ▼ -2.8 pp
2022 90.0% $243.20 Million $270.20 Million $27.00 Million ▲ +0.0 pp
2021 90.0% $252.56 Million $280.71 Million $28.15 Million ▲ +96.2 pp
2020 -6.2% $-3.15 Million $50.67 Million $53.81 Million ▲ +109.7 pp
2019 -115.9% $-22.08 Million $19.04 Million $41.12 Million —
pp = percentage points